Publikationen, an denen er mitarbeitet FRANCISCO JAVIER MENÁRGUEZ PALANCA (7)

2023

  1. Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell Lymphoma

    Transplantation and Cellular Therapy, Vol. 29, Núm. 7, pp. 472.e1-472.e4

2022

  1. Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment (BMC Cancer, (2022), 22, 1, (982), 10.1186/s12885-022-10070-z)

    BMC Cancer

  2. EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

    BMC Cancer, Vol. 22, Núm. 1

2021

  1. Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide

    Frontiers in Immunology, Vol. 12

  2. Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma

    Scientific Reports, Vol. 11, Núm. 1

2008

  1. Mesenteric inflammatory veno-occlusive disease (MIVOD) after allogeneic peripheral blood stem cell transplantation (PBSCT) [1]

    Bone Marrow Transplantation

2005

  1. Lymphoma associated chromosomal abnormalities can easily be detected by FISH on tissue imprints. An underused diagnostic alternative

    Journal of Clinical Pathology, Vol. 58, Núm. 6, pp. 629-633